Leveraged backtest · Thematic

Biotechnology (Nasdaq NBI): 2x and 3x vs 1x

Simulated 2x and 3x versions of Biotechnology (Nasdaq NBI), with daily reset and financing costs, compared with the same index unleveraged. Total return in USD.

Total return · 10 years
+221.6%
Biotechnology (Nasdaq NBI) 2x in USD · 1x +192.9%
Biotechnology (Nasdaq NBI) 2xBiotechnology (Nasdaq NBI) 1xBase 100 at start · shaded: approximated dividends

Metrics for Biotechnology (Nasdaq NBI) 2x

Annual return12.4%1x 11.4%
Max drawdown−66.9%1x −38.1%
Worst year · 2022−28.8%1x −10.2%
Time underwater5.5 years1x 4.2 years
Versus 1x · Ahead at the end, after a rough stretch

You end 10% ahead of 1x, and at worst you were 34% behind.

Cumulative edge of the leveraged product in this period · 0% = same as 1x

At the end+9.8%ahead
Worst point−34.0%Apr 2025
Time behind4.7 yearsof 10.0 years

Provisional thresholds: rough stretch if it was more than 20% behind or behind for more than 3 years.

Keep in mind

  • Series simulated with the study's model (same cost calibration for every index): not the price of a specific ETF.

Leverage on Biotechnology (Nasdaq NBI), period by period

The study’s model (s = 0.50%, m = 1.2, 0.90% fees for 2x and 3x), in USD with dividends. Here 1x is the index itself, without fees. Calculated with the same engine as the simulator. Data up to 30 Oct 2026. Updated on the 1st of every month.

Last 10 years

2016-10-31 → 2026-10-30 · 10.0 years
LeverageAnnual returnMax drawdownVersus 1x at the endWorst point versus 1xTime behind 1x
1x11.4%−38.1%———
2x12.4%−66.9%+9.8%−34.0%4.7 years
3x8.3%−86.9%−24.2%−70.7%5.7 years

Last 10 years: 2x returned 12.4% a year against 11.4% for 1x, with a max drawdown of 66.9%, and ended +9.8% versus 1x.

Last 20 years

2006-10-30 → 2026-10-30 · 20.0 years
LeverageAnnual returnMax drawdownVersus 1x at the endWorst point versus 1xTime behind 1x
1x12.4%−39.1%———
2x15.3%−67.2%+65.6%−42.7%5.2 years
3x12.4%−92.2%+0.6%−72.0%10.7 years

Last 20 years: 2x returned 15.3% a year against 12.4% for 1x, with a max drawdown of 67.2%, and ended +65.6% versus 1x.

Full series since 1993

1993-11-01 → 2026-10-30 · 33.0 years
LeverageAnnual returnMax drawdownVersus 1x at the endWorst point versus 1xTime behind 1x
1x12.1%−74.4%———
2x11.4%−97.1%−20.0%−72.3%27.1 years
3x3.1%−99.90%−93.7%−98.2%29.6 years

Full series since 1993: 2x returned 11.4% a year against 12.1% for 1x, with a max drawdown of 97.1%, and ended −20.0% versus 1x.

Real ETFs you can simulate
  • BIB · 2x · USD · United States · since 2010